Presentation TCT 2016 Issues With Non-inferiority Trials: Choosing the Margin and Comparator; Creep, Noise, and More Presenter: Roxana Mehran, Pascal Vranckx, Sanjay Kaul October 30, 2016
Presentation TCT 2016 Transcatheter Mitral Replacement Devices: An Update from the International Organization for Standardization (ISO) Cardiac Valves Committee Presenter: Elazer R. Edelman, Juan F. Granada, Changfu Wu, Aaron Chalekian October 30, 2016
Presentation TCT 2016 Stent Design and Comprehensive Data Review: BioMatrix Biolimus-Eluting Stents Presenter: Dean J. Kereiakes, Pieter C. Smits, Stephan Windecker October 30, 2016
Presentation TCT 2016 The Renal Nerves and Their Role in Hypertension: An Updated Synthesis (Anatomy and Pathophysiology) Presenter: Felix Mahfoud, Michael A. Weber, Michael Joner October 30, 2016
Presentation TCT 2016 Flash Debate: Counterpoint - Guidelines Have Limited Value in Rapidly Evolving Transcatheter Valve Therapies! Presenter: Patrick T. O'Gara, Alec S. Vahanian, John G. Webb October 30, 2016
Presentation TCT 2016 Animal Testing: Real-World Experiences and Translational Challenges Presenter: Elazer R. Edelman, Juan F. Granada, Changfu Wu October 30, 2016
Presentation TCT 2016 Stent Design and Comprehensive Data Review: Resolute Cobalt Chromium Durable Polymer-Based Zotarolimus-Eluting Stents Presenter: Dean J. Kereiakes, Pieter C. Smits, Roxana Mehran October 30, 2016
Presentation TCT 2016 Flash Debate: Point Guidelines Should Remain the Standard for Clinical Practice! Presenter: Patrick T. O'Gara, Alec S. Vahanian October 30, 2016
Presentation TCT 2016 Debate: What Is the Optimal Study Design for Maximizing Trial Efficiency, Success, and Interpretability? Adaptive Design in A Bayesian Framework! Presenter: Roxana Mehran, Pascal Vranckx, Scott Berry October 30, 2016
Presentation TCT 2016 Obtaining Informed Consent: The Essentials and How to Succeed in Difficult Scenarios Presenter: David A. Cox, Thomas D. Stuckey, Timothy D. Henry October 30, 2016
Presentation TCT 2016 Animal Testing: FDA Expectations Presenter: Elazer R. Edelman, Juan F. Granada, Changfu Wu, Natalie Miller October 30, 2016
Presentation TCT 2016 Is There a Role for PCI of Renal Artery Stenosis in Hypertension Management? Presenter: Felix Mahfoud, Michael A. Weber, Ehtisham Mahmud October 30, 2016
Presentation TCT 2016 Stent Design and Comprehensive Data Review: Platinum Chromium Everolimus-Eluting Stents - Evolution From the Fluoropolymer-Based Promus Element to the Bioabsorbable Polymer-Based Synergy Presenter: Dean J. Kereiakes, Pieter C. Smits October 30, 2016
Presentation TCT 2016 An Interesting Alternative: The New WikiRecs for TAVR Use in Lower Risk Patients Presenter: Patrick T. O'Gara, Alec S. Vahanian, Catherine M. Otto October 30, 2016
Presentation TCT 2016 Debate: What Is the Optimal Study Design for Maximizing Trial Efficiency, Success, and Interpretability? Adaptive Design in a Frequentist Framework! Presenter: Roxana Mehran, Pascal Vranckx, Stuart J. Pocock October 30, 2016
Presentation TCT 2016 How to Be a Key Investigator? Its Not Just Quantity- Quality Is Top Priority Presenter: David A. Cox, Thomas D. Stuckey October 30, 2016
Presentation TCT 2016 Whats Next for the Nurse/Tech Team? Presenter: Regina Deible, Mary K. Egan October 30, 2016
Presentation TCT 2016 FDA Perspectives Presenter: Elazer R. Edelman, Juan F. Granada, Changfu Wu October 30, 2016
Presentation TCT 2016 Future TAVR Guidelines: The Next ACC/AHA TAVR Focused Update and New Appropriate Use Criteria for TAVR Presenter: Patrick T. O'Gara, Alec S. Vahanian, Samir R. Kapadia October 30, 2016
Presentation TCT 2016 Choice of Primary (or Co-primary) Endpoints: Efficacy, Safety, or Net Clinical Benefit in Superiority and Non-inferiority Trials Presenter: Roxana Mehran, Pascal Vranckx, Robert A. Harrington October 30, 2016